Distinct miRNA expression in dorsal striatal subregions is associated with risk for addiction in rats

Translational Psychiatry

Volumn 5, Issue 2, 2015, Pages

  Quinn, R K ^a,b,c   Brown, A L ^a,b,c   Goldie, B J ^a,b,c   Levi, E M ^a,b,c   Dickson, P W ^a,b,c   Smith, D W ^a,b,c   Cairns, M J ^a,b,c   Dayas, C V ^a,b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; COCAINE; MESSENGER RNA; MICRORNA; MICRORNA 101B; MICRORNA 132; MICRORNA 181A; MICRORNA 212; MICRORNA 221; MICRORNA 222; MICRORNA 328; MICRORNA 342 5P; MICRORNA 495; MICRORNA 708; MICRORNA 7A; MICRORNA 99A; UNCLASSIFIED DRUG; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; MIRN212 MICRORNA, RAT; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL STRIATUM; DORSOLATERAL STRIATUM; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DRUG SEEKING BEHAVIOR; GENE EXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPIC VARIATION; POSTTRANSCRIPTIONAL GENE SILENCING; RAT; RELAPSE; RISK ASSESSMENT; SYNAPTIC TRANSMISSION; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NEOSTRIATUM;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DRUG-SEEKING BEHAVIOR; GENE EXPRESSION PROFILING; MICRORNAS; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; RATS; RNA, MESSENGER;

EID: 84927712962     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.144     Document Type: Article

References (43)

1. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005; 8: 1481-1489.
2. Balleine B, Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical susbtrates. Neuropharmacology 1998; 37: 407-419.
3. Balleine BW, O'Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2009; 35: 48-69.
4. Yin HH, Knowlton BJ, Balleine BW. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci 2004; 19: 181-189.
5. Yin HH, Ostlund SB, Knowlton BJ, Balleine BW. The role of the dorsomedial striatum in instrumental conditioning. Eur J Neurosci 2005; 22: 513-523.
6. Brown AL, Flynn JR, Smith DW, Dayas CV. Down-regulated striatal gene expression for synaptic plasticity-associated proteins in addiction and relapse vulnerable animals. Int J Neuropsychopharmacol 2010; 14: 1099-1110.
7. Deroche-Gamonet V, Belin D, Piazza PV. Evidence for addiction-like behavior in the rat. Science 2004; 305: 1014-1017.
8. Kasanetz F, Deroche-Gamonet V, Berson N, Balado E, Lafourcade M, Manzoni O et al. Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science 2010; 328: 1709-1712.
9. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF et al. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of longterm memory. J Neurosci 2000; 20: 3993-4001.
10. Ortiz O, Delgado-Garciá JM, Espadas I, Bahí A, Trullas R, Dreyer et al. Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R Null, Drd1a/Mice and in hippocampal siRNA silenced Drd1a mice. J Neurosci 2010; 30: 12288-12300.
11. Bramham C, Alme M, Bittins M, Kuipers S, Nair R, Pai B et al. The Arc of synaptic memory. Exp Brain Res 2010; 200: 125-140.
12. Yin HH, Knowlton BJ, Balleine BW. Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning. Behav Brain Res 2006; 166: 189-196.
13. Yin HH, Knowlton BJ, Balleine BW. Blockade of NMDA receptors in the dorsomedial striatum prevents action-outcome learning in instrumental conditioning. Eur J Neurosci 2005; 22: 505-512.
14. Belin D, Everitt BJ. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008; 57: 432-441.
15. Vanderschuren LJMJ, Di Ciano P, Everitt BJ. Involvement of the dorsal striatum in cue-controlled cocaine seeking. J Neurosci 2005; 25: 8665-8670.
16. Hollander JA, Im H-I, Amelio AL, Kocerha J, Bali P, Lu Q et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010; 466: 197-202.
17. Im H-I, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010; 13: 1120-1127.
18. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
19. Chandrasekar V, Dreyer J-L. Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaineinduced conditioned place preference. Neuropsychopharmacology 2011; 36: 1149-1164.
20. Dayas CV, Smith DW, Dunkley PR. An emerging role for the mammalian Target of Rapamycin (mTOR) in 'pathological' protein translation: relevance to cocaine addiction. Front Pharmacol 2012; 3.
21. James MH, Quinn RK, Ong LK, Levi EM, Charnley JL, Smith DW et al. mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKII levels. Neuropsychopharmacology 2014, 39: 1694-1702.
22. Gardiner E, Carroll A, Tooney PA, Cairns MJ. Antipsychotic drug-associated gene-miRNA interaction in T-lymphocytes. Int J Neuropsychopharmacol 2014; 17: 929-943.
23. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17: 1156-1168.
24. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010; 15: 1176-1189.
25. Ong L, Sominsky L, Dickson P, Hodgson D, Dunkley P. The sustained phase of tyrosine hydroxylase activation in vivo. Neurochem Res 2012; 37: 1938-1943.
26. Carroll A, Tran N, Tooney P, Cairns M. Alternative mRNA fates identified in microRNA-associated transcriptome analysis. BMC Genomics 2012; 13: 561.
27. Carroll AP, Tooney PA, Cairns MJ. Design and interpretation of microRNA-reporter gene activity. Anal Biochem 2013; 437: 164-171.
28. Neasta J, Ben Hamida S, Yowell Q, Carnicella S, Ron D. Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proc Natl Acad Sci USA 2010; 107: 20093-20098.
29. Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A et al. N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 2009; 12: 182-189.
30. Chandrasekar V, Dreyer J-L. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 2009; 42: 350-362.
31. Hearing M, See R, McGinty J. Relapse to cocaine-seeking increases activityregulated gene expression differentially in the striatum and cerebral cortex of rats following short or long periods of abstinence. Brain Struct Funct 2008; 213: 215-227.
32. Hearing MC, Schwendt M, McGinty JF. Suppression of activity-regulated cytoskeleton-associated gene expression in the dorsal striatum attenuates extinction of cocaine-seeking. Int J Neuropsychopharmacol 2010; 14: 784-795.
33. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG et al. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeletonassociated protein that is enriched in neuronal dendrites. Neuron 1995; 14: 433-445.
34. Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N et al. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 2006; 52: 445-459.
35. Jakkamsetti V, Tsai N-P, Gross C, Molinaro G, Collins Katie A, Nicoletti F et al. Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabotropic glutamate receptor-dependent long-term synaptic depression. Neuron 2013; 80: 72-79.
36. Kim JH, Perry C, Luikinga S, Zbukvic I, Brown RM, Lawrence AJ. Extinction of a cocaine-taking context that protects against drug-primed reinstatement is dependent on the metabotropic glutamate 5 receptor. Addict Biol 2014.
37. Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 2006; 52: 437-444.
38. Mameli M, Halbout B, Creton C, Engblom D, Parkitna JR, Spanagel R et al. Cocaineevoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat Neurosci 2009; 12: 1036-1041.
39. Corbit LH, Chieng BC, Balleine BW. Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine. Neuropsychopharmacology 2014; 39: 1893-1901.
40. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 2007; 10: 1029-1037.
41. Jeanblanc J, He D-Y, Carnicella S, Kharazia V, Janak PH, Ron D. Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci 2009; 29: 13494-13502.
42. Wu D, Murashov AK. MicroRNA-431 regulates axon regeneration in mature sensory neurons by targeting the Wnt antagonist Kremen1. Front Mol Neurosci 2013; 6: 35.
43. Haling Jacob R, Sudhamsu J, Yen I, Sideris S, Sandoval W, Phung W et al. Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling. Cancer Cell 26: 402-413.